Trials / Completed
CompletedNCT05581758
A Study to Assess the Effect of Food on the Pharmacokinetics (PK) of AMG 510 in Healthy Participants
An Open-label, Randomized, 2-period, 2-treatment Crossover Study to Assess the Effect of Food on the Pharmacokinetics of AMG 510 in Healthy Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 14 (actual)
- Sponsor
- Amgen · Industry
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
The primary objective of the study is to evaluate the PK of AMG 510 administered in the fasted and fed state in healthy participants.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | AMG 510 | Oral Tablet |
Timeline
- Start date
- 2019-11-14
- Primary completion
- 2019-11-25
- Completion
- 2019-12-09
- First posted
- 2022-10-17
- Last updated
- 2025-03-05
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT05581758. Inclusion in this directory is not an endorsement.